REQUEST A DEMO
Total
USD $0.00
Search more companies

B-Crobes Laboratory Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: B-Crobes Laboratory Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

B-Crobes Laboratory Sdn. Bhd. is a company in Malaysia, with a head office in Subang Jaya. It operates in the Pharmacies and Drug Stores sector. It was first established on August 08, 2002. There was a net sales revenue increase of 69.47% reported in B-Crobes Laboratory Sdn. Bhd.’s latest financial highlights for 2022. There was a total growth of 30.56% in B-Crobes Laboratory Sdn. Bhd.’s total assets over the same period. The net profit margin of B-Crobes Laboratory Sdn. Bhd. increased by 21.08% in 2022.

Headquarters
No. 31-B Jalan Usj 10/1E
Subang Jaya; Selangor; Postal Code: 47620

Contact Details: Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.

Website: http://www.bcrobes.com

Basic Information
Outstanding Shares:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Incorporation Date:
August 08, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
78.35%
Purchase this report to view the information.
21.65%
Company Performance
Financial values in the chart are available after B-Crobes Laboratory Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
69.47%
Total operating revenue
69.47%
Operating profit (EBIT)
513.98%
EBITDA
333.8%
Net Profit (Loss) for the Period
588.17%
Total assets
30.56%
Total equity
89.22%
Operating Profit Margin (ROS)
26.75%
Net Profit Margin
21.08%
Return on Equity (ROE)
34.19%
Debt to Equity Ratio
-90.53%
Quick Ratio
1.16%
Cash Ratio
1.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?